Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

CNS 21Breast 14Thoracic 6Other hematologic neoplasm 6Lymphoid 5Gastrointestinal 5Tumor-Agnostic 4Sarcoma 2Plasma cell 2Other solid neoplasm 2Head & Neck 2Genitourinary 2Myeloid 1

Conditions

Neoplasms 4

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Mental Status and Dementia Tests × Tumor-Agnostic × Clear all
NCT06160700 2024-06-10

Serial Testing To Assess Cognitive Function In Cancer

Indiana University

Terminated
54 enrolled
Tumor-Agnostic

Neoplasms

NCT01506440 2018-07-03

Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy

Wake Forest University Health Sciences

Completed
29 enrolled
Tumor-Agnostic

Neoplasms

NCT02558907 2017-04-04

MoCA

Centre Francois Baclesse

Completed
66 enrolled
Tumor-Agnostic

Neoplasms

NCT03052868 2017-02-14

Analysis of Neurocognitive Elements of Attention After Chemotherapy

University of Texas Southwestern Medical Center

Phase NA Completed
75 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡